This Review discusses the evolving landscape of biomedical HIV prevention technologies for women in Africa—who bear a disproportionate burden of new infections—and the cost-effectiveness, implementation and financing of these tools.
- Frances M. Cowan
- Maryam Shahmanesh
- Andrew N. Phillips